Tomohito Gohda

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 17

Top Venues

International journal of molecular sciences

Diagnostics (Basel, Switzerland)

Journal of diabetes investigation

FEBS open bio

Juntendo University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Juntendo University

Japan

PHD :: Nephrology

Publications

Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, Jun Okabe, Maki Murakoshi, Yusuke Suzuki
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. International journal of molecular sciences 25 (2) (2024)
Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, Jun Okabe, Maki Murakoshi, Yusuke Suzuki
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. International journal of molecular sciences 25 (2) (2024)
Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, Jun Okabe, Maki Murakoshi, Yusuke Suzuki
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. International journal of molecular sciences 25 (2) (2024)
Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, Jun Okabe, Maki Murakoshi, Yusuke Suzuki
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. International journal of molecular sciences 25 (2) (2024)
Yuichiro Yano, Akira Nishiyama, Yusuke Suzuki, Satoshi Morimoto, Takashi Morikawa, Tomohito Gohda, Hiroshi Kanegae, Naoki Nakashima
Relevance of ChatGPT's Responses to Common Hypertension-Related Patient Inquiries. Hypertension (Dallas, Tex. : 1979) (2023)
Takeo Koshida, Tomohito Gohda, Takuya Sugimoto, Takashi Asahara, Rin Asao, Isao Ohsawa, Hiromichi Gotoh, Maki Murakoshi, Yusuke Suzuki, Yuichiro Yamashiro
Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease. International journal of molecular sciences 24 (14) (2023)
Maki Murakoshi, Takashi Kobayashi, Masao Kihara, Seiji Ueda, Yusuke Suzuki, Tomohito Gohda
The proteinuria-lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease. Nephrology (Carlton, Vic.) (2023)
Tomohito Gohda, Maki Murakoshi
Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials. International journal of molecular sciences 23 (22) (2022)
Maki Murakoshi, Takumi Iwasawa, Takeo Koshida, Yusuke Suzuki, Tomohito Gohda, Kazunori Kato
Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Maki Murakoshi, Takumi Iwasawa, Takeo Koshida, Yusuke Suzuki, Tomohito Gohda, Kazunori Kato
Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Tomohito Gohda, Maki Murakoshi, Yusuke Suzuki, Makoto Hiki, Toshio Naito, Kazuhisa Takahashi, Yoko Tabe
Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients. PloS one 17 (10) (2022)
Maki Murakoshi, Takumi Iwasawa, Takeo Koshida, Yusuke Suzuki, Tomohito Gohda, Kazunori Kato
Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Maki Murakoshi, Tomohito Gohda, Yusuke Suzuki
Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease. International journal of molecular sciences 21 (6) (2020)
Tomohito Gohda, Nozomu Kamei, Mitsunobu Kubota, Kanako Tanaka, Yoshinori Yamashita, Hiroko Sakuma, Chiaki Kishida, Eri Adachi, Takeo Koshida, Maki Murakoshi, Shinji Hagiwara, Kazuhiko Funabiki, Seiji Ueda, Yusuke Suzuki
Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function. Journal of diabetes investigation 12 (3) (2020)
Zi Li, Maki Murakoshi, Saki Ichikawa, Takeo Koshida, Eri Adachi, Chigure Suzuki, Seiji Ueda, Tomohito Gohda, Yusuke Suzuki
The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice. FEBS open bio 10 (12) (2020)
Saki Ichikawa, Tomohito Gohda, Maki Murakoshi, Zi Li, Eri Adachi, Takeo Koshida, Yusuke Suzuki
Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice. FEBS open bio 10 (6) (2020)
Tomohito Gohda, Nozomu Kamei, Takeo Koshida, Mitsunobu Kubota, Kanako Tanaka, Yoshinori Yamashita, Eri Adachi, Saki Ichikawa, Maki Murakoshi, Seiji Ueda, Yusuke Suzuki
Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. Journal of diabetes investigation 11 (2) (2019)
Tomohito Gohda, Akira Mima, Ju-Young Moon, Keizo Kanasaki
Combat diabetic nephropathy: from pathogenesis to treatment. Journal of diabetes research 2014 (2014)

Tomohito Gohda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tomohito Gohda